Construction and in vitro/in vivo targeting of PSMA-targeted nanoscale microbubbles in prostate cancer (Q34637387)

3 August 2017

title

Construction and in vitro/in vivo targeting of PSMA-targeted nanoscale microbubbles in prostate cancer (English)

1 reference

3 August 2017

1 reference

1 reference

Luofu Wang

1

1 reference

3 August 2017

Lang Li

2

1 reference

3 August 2017

Yanli Guo

3

1 reference

3 August 2017

Haipeng Tong

4

1 reference

3 August 2017

Xiaozhou Fan

5

1 reference

3 August 2017

Jun Ding

6

1 reference

3 August 2017

Haiyun Huang

7

1 reference

3 August 2017

publication date

26 March 2013

1 reference

3 August 2017

1 reference

3 August 2017

volume

73

1 reference

3 August 2017

issue

11

1 reference

3 August 2017

page(s)

1147-1158

1 reference

Ultrasound molecular imaging of VEGFR2 in a rat prostate tumor model using BR55.

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22663

Nanobody-coupled microbubbles as novel molecular tracer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22663

Detection of individual microbubbles of ultrasound contrast agents: imaging of free-floating and targeted bubbles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22663

PET/CT Imaging and Radioimmunotherapy of Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22663

Prostate-specific membrane antigen expression as a predictor of prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22663

Prostate-specific membrane antigen (PSMA) protein expression in normal and neoplastic tissues and its sensitivity and specificity in prostate adenocarcinoma: an immunohistochemical study using mutiple tumour tissue microarray technique.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22663

Innovative biomarkers for prostate cancer early diagnosis and progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22663

New horizons in prostate cancer imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22663

Left ventricular thrombus enhancement after intravenous injection of echogenic immunoliposomes: studies in a new experimental model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22663

Molecular imaging of inflammation in atherosclerosis with targeted ultrasound detection of vascular cell adhesion molecule-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22663

Microbubbles in ultrasound-triggered drug and gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22663

Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22663

Clinical utility of radiolabeled monoclonal antibodies in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22663

In vitro targeted photodynamic therapy with a pyropheophorbide--a conjugated inhibitor of prostate-specific membrane antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22663

Development of polymeric microbubbles targeted to prostate-specific membrane antigen as prototype of novel ultrasound contrast agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22663

Vascular targeted therapy with anti-prostate-specific membrane antigen monoclonal antibody J591 in advanced solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22663

21 January 2018

Identifiers

DOI

10.1002/PROS.22663

1 reference

3 August 2017

1 reference